Guardant Health, Inc.
GH
$129.69
-$3.53-2.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -112.08M | -128.49M | -92.73M | -99.90M | -95.16M |
| Total Depreciation and Amortization | 9.44M | 10.05M | 9.41M | 10.04M | 10.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.28M | 59.78M | 51.04M | 49.81M | 45.57M |
| Change in Net Operating Assets | -23.27M | 32.29M | -3.14M | -20.24M | -23.34M |
| Cash from Operations | -65.62M | -26.37M | -35.41M | -60.29M | -62.69M |
| Capital Expenditure | -5.58M | -27.85M | -10.35M | -5.65M | -4.46M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -58.99M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 705.00M | -818.23M | -4.00M | -5.00M | 307.32M |
| Cash from Investing | 699.42M | -905.07M | -14.35M | -10.65M | 302.86M |
| Total Debt Issued | -- | 397.47M | 5.03M | -5.03M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.65M | 364.08M | 3.72M | 9.24M | 768.00K |
| Repurchase of Common Stock | -20.65M | -5.35M | -2.27M | -7.42M | -60.51M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.58M | -24.17M | -2.16M | 4.84M | -7.11M |
| Cash from Financing | -21.58M | 732.03M | 4.33M | 1.62M | -66.85M |
| Foreign Exchange rate Adjustments | -194.00K | -686.00K | -533.00K | 937.00K | 773.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 612.02M | -200.10M | -45.97M | -68.37M | 174.10M |